Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antigen[C268]" in comments (approximate match)

Showing 11 - 20 of 89 results

First page
Previous page
2
Next page
Next page

HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN

Z845VHQ61P

Subunit 1 (501) Similarity Search

Sequence Search

Subunit 1 (501) Similarity Search

Status:

Possibly Marketed Outside US

Source:

NCT03051516: Phase 4 Interventional Terminated High Grade Anal Canal Intraepithelial Neoplasia

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03051516

First approved in 2006

Source:

BLA125126

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab802261-3eeb-4eea-af6a-31c830ac91f8

Class:

PROTEIN

HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN

61746O90DY

Subunit 1 (138) Similarity Search

Sequence Search

Subunit 1 (138) Similarity Search

Status:

Possibly Marketed Outside US

Source:

NCT03051516: Phase 4 Interventional Terminated High Grade Anal Canal Intraepithelial Neoplasia

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03051516

First approved in 2006

Source:

BLA125126

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30952400-0572-4431-9150-3a41affffb9a

Class:

PROTEIN

SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN

7194H8W3KT

Status:

US Approved Rx (2000)

Source:

BLA103936

(2000)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1994

Source:

BLA103936

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5f674a82-00fb-41f8-99a5-df8985771324

Class:

POLYMER

STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE ANTIGEN

CGS5KI3Q2M

Status:

US Approved Rx (1977)

Source:

BLA101094

(1977)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1977

Source:

BLA101094

Source URL:

https://www.fda.gov/media/113210/download

Class:

POLYMER

STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN

S46U1CM432

Status:

US Approved Rx (1977)

Source:

BLA101094

(1977)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1977

Source:

BLA101094

Source URL:

https://www.fda.gov/media/113210/download

Class:

POLYMER

STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE ANTIGEN

4FVB62AFF1

Status:

US Approved Rx (1977)

Source:

BLA101094

(1977)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1977

Source:

BLA101094

Source URL:

https://www.fda.gov/media/113210/download

Class:

POLYMER

STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN

3RED79E75R

Status:

US Approved Rx (1977)

Source:

BLA101094

(1977)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1977

Source:

BLA101094

Source URL:

https://www.fda.gov/media/113210/download

Class:

POLYMER

STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN

N967BGT6XW

Status:

US Approved Rx (1977)

Source:

BLA101094

(1977)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1977

Source:

BLA101094

Source URL:

https://www.fda.gov/media/113210/download

Class:

POLYMER

STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN

328VNB72T8

Status:

US Approved Rx (1977)

Source:

BLA101094

(1977)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1977

Source:

BLA101094

Source URL:

https://www.fda.gov/media/113210/download

Class:

POLYMER

STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN

H9NOI61UH1

Status:

US Approved Rx (1977)

Source:

BLA101094

(1977)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1977

Source:

BLA101094

Source URL:

https://www.fda.gov/media/113210/download

Class:

POLYMER

Protein

HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN

Protein

HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN

7194H8W3KT
Not a public record

Structure of SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN

Polymer

SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN

Structure of STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE ANTIGEN

Polymer

STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE ANTIGEN

Structure of STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN

Polymer

STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN

Structure of STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE ANTIGEN

Polymer

STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE ANTIGEN

Structure of STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN

Polymer

STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN

Structure of STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN

Polymer

STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN

Structure of STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN

Polymer

STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN

Structure of STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN

Polymer

STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN

Showing 11 - 20 of 89 results

First page
Previous page
2
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1